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Mental and substance use disorders dominate the top ten global causes of non-
communicable diseases across the lifespan (Gore et al., 2011; World Health Organization, 
2011). The co-existence of mental and substance use disorders (dual diagnosis) occurs in 
approximately 25-50 percent of substance users (Teesson et al., 2012), and is even higher 
when sub-threshold mental health symptoms are considered (Guest and Holland, 2011). 
Despite growing recognition and a rapidly increasing international evidence base for effective 
treatments, a serious level of unmet need for treatment exists for people experiencing dual 
diagnosis. The translation of evidence-based treatment into practice is weak, and a critical 
gap exists between what we "know" and what we "do" in utilizing effective treatments for 
this highly disadvantaged client group. In spite of the publication of guidelines promoting 
integrated care (e.g. Department of Health (UK), 2002) and treatment competency 
frameworks (e.g. Hughes, 2006), a decade later integrated care still remains an unfulfilled 
vision for many mainstream healthcare services and is mostly confined to specialist treatment 
units (van Wamel et al., 2015). It is essential that we transport empirically tested treatment 
models to the frontline of healthcare in order to ensure a better response to dual diagnosis. 
 
The purpose of this novel special issue is to overcome a key barrier for the dissemination of 
psychological interventions into practice, by supporting the public accessibility of evidence-
based treatment manuals and implementation guides for comorbid mental and substance 
use disorders. Our intentions for this special issue are twofold. First, we aspire to facilitate 
further research and replication of comorbidity treatment models internationally, thereby 
growing and strengthening the field and improving what we "know." Second, we seek to 
enable clinicians across primary, secondary and tertiary services to implement high-quality, 
theoretically grounded and empirically-supported psychosocial treatments with people 
experiencing mental and substance use disorders, thereby improving what we "do." 
 
This issue brings together a collection of papers that describe the treatment procedures for 
comorbid presentations encountered in diverse clinical settings. The diversity of treatment 
approaches described in this issue reflects the very nature of comorbidity: where the 
combination of heterogeneous diagnostic, demographic and contextual features can 
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complicate treatment. Furthermore, these papers acknowledge and address the unique 
challenges of working in outpatient, inpatient and custodial settings. The contributions 
include an enhanced motivational intervention for young people with substance use 
problems and comorbid depression/anxiety (Hides et al., 2016), a brief integrated 
motivational intervention for substance use with psychiatric hospital inpatients (Graham et 
al., 2016), behavioral activation treatments for major depressive disorder and comorbid 
substance use disorders (Daughters et al., 2016; MacPherson et al., 2016); impulsive lifestyle 
counseling (ILC) for patients with antisocial personality disorder and substance use disorders 
(Hesse and Thylstrup, 2016); and substance use interventions applied in a high security 
personality disorder treatment unit (Bennett and Hunter, 2016). Not only are the 
comorbidities targeted by these interventions highly prevalent, but they often impose a large 
toll on individuals experiencing these conditions, clinicians assisting people to regain 
functional and symptomatic recovery, and also broader society (e.g. lost productivity, 
healthcare and criminal justice costs). 
 
Each paper is structured similarly, by first placing the treatment described within the context 
of the targeted comorbid conditions and the treatment settings where these conditions are 
commonly encountered. Theoretical concepts are presented as a foundation for the 
treatment approach, with specific procedures, illustrative case examples, examples of 
clinician-client dialogue, and research evidence providing a practical guide to implementation 
in these treatment settings. Examples of worksheets and homework activities are included 
where available, along with instructional details about how to implement the core cognitive, 
behavioral, psycho-educational and motivational strategies. Importantly, suggestions to 
enhance engagement and adherence to the treatment protocols are provided, along with 
strategies to maintain confidentiality and minimize risk to the person and clinician. These final 
points are critically important and are frequent barriers experienced by people with 
comorbidity when attempting to access and complete a treatment program (Baker et al., 
2014). Discussion sections highlight the potential areas for expansion of the treatment 
protocols beyond the comorbidities described and the settings in which they have been 
trialed, including suggested directions for future research. 
 
The theoretical basis underpinning the treatments described in this special issue is generally 
cognitive behavioral in nature. Some treatments, however, enhance this model by integrating 
motivational interviewing strategies (QuikFix, BIMI, InsideOut treatment models), behavioral 
activation (LETS ACT, BATS treatment models) and psycho-education (Iceberg, ILC treatment 
models) into a comorbidity-specific treatment package. A significant innovation is the 
ƚĂŝůŽƌŝŶŐŽĨƐŽŵĞŽĨƚŚĞƐĞŝŶƚĞƌǀĞŶƚŝŽŶƐƚƌĂƚĞŐŝĞƐƚŽƚŚĞĐůŝĞŶƚ ?ƐƉĞƌƐŽŶĂůŝƚǇŽƌƌĞůĂƚŝŶŐƐƚǇůĞ
(e.g. ILC, Iceberg, QuikFix), which has important implications for the design and delivery of 
future programs tailored to the specific challenges in treating young people, people with 
difficulties related to personality and interpersonal factors, and those who are "coerced" into 
care (e.g. by virtue of a custodial sentence). It is evident in these emerging approaches to 
behavior change that our field is moving in the direction of tailored interventions; attending 
ƚŽ ŝŵƉŽƌƚĂŶƚ ĂƐƉĞĐƚƐ ŽĨ ĐůŝĞŶƚƐ ? ĚĞŵŽŐƌĂƉŚŝĐ ĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ ? ĚŝĂŐŶŽƐƚŝĐ ƉƌĞƐĞŶƚĂƚŝŽŶƐ ?
personality features and social life contexts. We welcome this move toward personalized care 
in a way that is grounded in theory and supporting data. Furthermore, treatments have been 
designed so that they can be delivered by virtually any health professional working with 
people experiencing comorbidity, across a range of inpatient, outpatient, community and 
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forensic settings. If this international collection of papers offers us a window to the future of 
psychological care for complex cases, we will see more personalized, brief, parsimonious, 
flexible and accessible interventions in future. 
 
Common to all treatments are the key principles of expressing empathy, minimizing the use 
of labeling behaviors in pejorative terms, seeing the client as a person who is operating in a 
context of social, familial and other environmental challenges. A noteworthy aspect of some 
of the treatments described in this issue (LETS ACT, BATS, ILC) is the explicit need to attend 
ƚŽ ĐůŝĞŶƚƐ ? ƉĞƌƐŽŶĂů ǀĂůƵĞƐ ? ŝŶƚĞƌĞƐƚƐ ĂŶĚ ĂƐƉŝƌĂƚŝŽŶƐ ? dŚŝƐ ŝƐ ůŝŬĞůǇ ƚŽ ĞŶĂďůĞ ĐůŝŶŝĐŝĂŶƐ ƚŽ
establish and strengthen the therapeutic alliance, using idiographic information (e.g. personal 
values and goals) to guide behavior change in a way that is contextually adaptive and 
personally meaningful to the individual. The clinical wisdom of attending to empathy and the 
alliance as important drivers of treatment outcome is backed up by evidence from meta-
analyses (Elliott et al., 2011; Horvath et al., 2011). It is also known that certain personality 
traits are associated with poorer outcomes (e.g. impulsivity is associated with chronic 
substance use; Moeller and Dougherty, 2002) and require targeted interventions (e.g. 
reactant/resistant patients respond better to non-directive approaches; Beutler et al., 2011). 
Consistent with the evidence, these treatment approaches guide clinicians on how to adapt 
language, questioning techniques, therapeutic style (e.g. more or less directive) and provision 
ŽĨƚƌĞĂƚŵĞŶƚƐƚƌĂƚĞŐŝĞƐĂĐĐŽƌĚŝŶŐƚŽƚŚĞĐůŝĞŶƚ ?ƐƉƌĞƉĂƌĞĚŶĞƐƐƚŽĨŽĐƵƐŽŶƉĂƌƚŝĐƵůĂƌĂƐƉĞĐƚƐ
of their current situation. These principles are similar to those put forward by Guest and 
Holland (2011) for supporting individuals with complex presentations, reflecting best practice 
and expert advice in comorbidity treatment planning and delivery. 
 
Twenty years ago, Hall (1996) called for urgent attention to the treatment of comorbid mental 
health and substance use disorders. Researchers were urged to include, rather than exclude, 
people with these comorbid conditions in studies that test the effectiveness of treatments 
for either condition as a single focus, and more particularly that researchers should 
additionally focus on developing and testing interventions specifically for people with such 
comorbidity (Hall, 1996). We are pleased to report that significant effort and attention has 
been paid to both of these goals in the intervening period, and although much work remains 
to be done, this special issue demonstrates how traditional treatments can be enhanced into 
a comorbidity-specific, effective treatment package. It is important to remark that the 
dissemination of these interventions (and other evidence-based approaches not covered in 
this special issue) should be supported by adequate training and clinical supervision. Much 
work remains to be done on exploring the most feasible and cost-effective ways to train 
practitioners to implement such approaches competently in routine care, particularly as 
financial constraints and organizational pressures may work against our efforts to close the 
science-practice gap. We also advise the reader that, despite promising pilot data, solid 
grounding in theory, and rigorous peer review, the interventions reported in this special issue 
are still novel and some have only preliminary empirical support. There is a need, as always, 
for replication to occur, and for efficacy and effectiveness trials to be conducted and 
published to continue to build a solid evidence base for the treatment of a range of 
comorbidities described herein. It is our hope that this special issue will help to facilitate this. 
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